Delivery Order SPE2DB24D2100-SPE2DB25FBFJN
- Not listed
- The Defense Logistics Agency awarded a $5,078.30 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Lonsurf (15 mg-6.14 mg tablets) in quantities of 20 units. This contract represents a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 29, 2025. The delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of LONSURF (15 mg-6.14 mg tablets) in a quantity of 40 units, with a ceiling value of $5,124.17 and firm fixed pricing. This delivery order, which is not set-aside, is scheduled for completion by August 28, 2025, with performance occurring at the vendor's location in Conshohocken, Pennsylvania. The award represents a competitive procurement under AmerisourceBergen's broader...
- This is a $7,685.32 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LONSURF 15 MG-6.14 MG tablets, which are used for medical treatment. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,092.24, is for the delivery of LONSURF 15 MG-6.14 MG tablets. The contract has an ultimate completion date of April 22, 2025 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,124.17, is for the supply of the drug LONSURF 15 MG-6.14 MG TABLET 40S. The contract has an ultimate completion date of April 4, 2025 and a firm fixed price pricing type. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp also holds a $999,999,999 Indefinite...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,124.17, is a Firm Fixed Price Delivery Order for a pharmaceutical product called LONSURF 15 MG-6.14 MG TABLET 40S. The award has an ultimate completion date of February 21, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $4,835.01 firm fixed price delivery order is for the supply of 4564118881 - LONSURF 15 MG-6.14 MG TABLET 40S, a pharmaceutical product. The contract has an ultimate completion date of April 19, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LONSURF 20 MG-8.19 MG tablets. The contract has a firm fixed price of $8,531.96 and an ultimate completion date of September 19, 2024. This contract is not set aside for any particular business type. AmerisourceBergen, through its extensive federal contracting experience and supply chain capabilities, will provide these critical...
- This federal contract award, identified as SPE2DB22D3004|SPE2DB25FQL42, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,406.92 firm fixed-price delivery order is for the supply of the medication LONSURF 20 MG-8.19 MG TABLET 20S. The contract has an ultimate completion date of May 19, 2025. AmerisourceBergen Drug Corp, a for-profit corporate entity, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- The Defense Logistics Agency awarded a $9,086.68 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 40 tablets of Lonsurf 15 mg-6.14 mg to treat cancer. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the chemotherapy medication from its facility in Conshohocken, Pennsylvania to the Defense Logistics Agency by September 5, 2023 to support the agency's mission. No subcontractors or set aside designations were identified in the award information. The...
- SPE2DB24D2100Indefinite Delivery Contract
- SPE2DB24D2100-SPE2DB25FBFJNDelivery Order
The Defense Logistics Agency awarded a $6,760.14 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Lonsurf (20 mg-8.19 mg tablets) in quantities of 40 units. This is a firm fixed price contract with an ultimate completion date of August 12, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, holds a $999.999 billion IDC with DLA Troop Support Medical (designated SPE2DX) running through December 2026, which serves as the parent contract vehicle for this delivery order. The company supplies a comprehensive portfolio of pharmaceutical products to support military and veteran healthcare systems, including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains. This delivery order for Lonsurf—a combination chemotherapy medication used in cancer treatment—exemplifies AmerisourceBergen's role as a key provider of specialized medical commodities to the Defense Health Agency and other federal healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 7/22/25 |